This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jui-Hsin Huang: Innovator in Clostridium Difficile Research
Introduction
Jui-Hsin Huang is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of Clostridium difficile-associated diseases. His innovative work has led to the development of valuable patents that aim to improve health outcomes.
Latest Patents
Jui-Hsin Huang holds a patent for "Compositions and methods for treating clostridium difficile-associated diseases." This patent describes isolated polypeptides that contain one or more receptor-binding sites of toxin A (tcdA) of Clostridium difficile. It also includes nucleic acids encoding these polypeptides and methods for utilizing them in treatment.
Career Highlights
Huang is affiliated with the National Health Research Institutes, where he conducts research aimed at addressing critical health issues. His work is characterized by a commitment to advancing medical science and improving patient care through innovative solutions.
Collaborations
Throughout his career, Jui-Hsin Huang has collaborated with esteemed colleagues, including Pele Choi-Sing Chong and Chih-Hsiang Leng. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.
Conclusion
Jui-Hsin Huang's contributions to the field of medical research, particularly in combating Clostridium difficile-associated diseases, highlight his role as an influential inventor. His patent and collaborative efforts reflect a dedication to improving health through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
